Newswise — ARLINGTON, VA. (July 3, 2017) – The American Association of Pharmaceutical Scientists (AAPS) is very pleased to announce that The AAPS Journal, AAPS PharmSciTech and Pharmaceutical Research continue to successfully disseminate quality content to the pharmaceutical sciences community. According to Clarivate Analytics’ 2016 Journal Citation Reports, AAPS PharmSciTech’s Impact Factor (IF) increased from 1.954 in 2015 to 2.451 this year. In fact, in 2016 there were 5,222 citations to 318 items published in the journal in 2014 and 2015!
“On behalf of the editors and editorial board of AAPS PharmSciTech, I am very pleased that the journal's impact factor continues to improve as a direct reflection of the high influence and relevant papers published in the journal by our peers, and I thank the authors whose papers have made this possible,” noted AAPS PharmSciTech Editor-in-Chief Robert O. (Bill) Williams III, Ph.D.
The AAPS Journal (AAPSJ) held firm with an IF of 3.423, with 4,659 citations to 289 items published in 2014–15. AAPSJ is currently ranked 65 of 256 titles in Pharmacology and Pharmacy. Pharmaceutical Research has a strong IF of 3.002, ranking 87 out of 256.
The 2016 IF ranking system is based on the number of times articles published in the previous two years were cited in 2016. It is one of a number of tools, also including downloads, peer review metrics, Immediacy Index and EigenFactor, used by the publisher, authors and librarians to determine the ranking of journals in their particular field of study and value in purchasing a subscription.
The AAPS Journal
The AAPS Journal, an official journal of the American Association of Pharmaceutical Scientists (AAPS), publishes novel and significant findings in the various areas of pharmaceutical sciences impacting human and veterinary therapeutics, including: Drug Design and Discovery; Pharmaceutical Biotechnology; Biopharmaceutics, Formulation, and Drug Delivery; Metabolism and Transport; Pharmacokinetics, Pharmacodynamics, and Pharmacometrics; Translational Research; Clinical Evaluations and Therapeutic Outcomes and Regulatory Science.
AAPS PharmSciTech is a peer-reviewed, online-only journal committed to serving those pharmaceutical scientists and engineers interested in the research, development, and evaluation of pharmaceutical dosage forms and delivery systems, including drugs derived from biotechnology and the manufacturing science pertaining to the commercialization of such dosage forms.
Pharmaceutical Research, an official journal of the AAPS, presents papers which describe innovative research spanning the entire spectrum of drug discovery, development, evaluation, and regulatory approval. Small drug molecules, biotechnology products including genes, peptides, proteins and vaccines, and genetically engineered cells are an integral part of papers published here. Current emphasis of the journal includes the following areas: preformulation; drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; molecular biopharmaceutics and drug disposition; and computational biopharmaceutics, among others.
Congratulations and a special thank you to our editors and editorial teams for their efforts to achieve this success!
Please visit our website for more information about AAPS Journals.
About AAPS: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 9,000 members employed in academia, industry, government, and other research institutes worldwide. Founded in 1986, AAPS advances the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Visit www.aaps.org today and follow us on Twitter and Facebook, hashtag #AAPS2017.